118 related articles for article (PubMed ID: 22906200)
1. Correlation between asymptomatic leukocyturia and urinary N-acetyl-β-d-glucosaminidase in women.
Sekimizu K; Suzuki T; Igari Y; Okazaki M; Hashimoto M; Suzuki K; Ouchi M; Watanabe K; Nakano H; Oba K
Ren Fail; 2012; 34(9):1079-83. PubMed ID: 22906200
[TBL] [Abstract][Full Text] [Related]
2. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic leukocyturia and the autonomic nervous system in women.
Igari Y; Oba K; Yamamoto Y; Yasuoka H; Ouchi M; Watanabe K; Matsumura N; Suzuki T; Nakano H
Geriatr Gerontol Int; 2009 Jun; 9(2):190-6. PubMed ID: 19740363
[TBL] [Abstract][Full Text] [Related]
4. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
6. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
[TBL] [Abstract][Full Text] [Related]
7. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
8. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
10. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
Hirai M; Nakano H; Oba K; Metori S
Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
[TBL] [Abstract][Full Text] [Related]
11. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
[TBL] [Abstract][Full Text] [Related]
12. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
Suzuki T; Igari Y; Oba K
Nihon Rinsho; 2005 Jun; 63 Suppl 6():352-7. PubMed ID: 15999733
[No Abstract] [Full Text] [Related]
13. [Urinary N-acetyl-beta-D-glucosaminidase and gamma-glutamyl-transpeptidase activities for evaluation of renal disturbance in patients with multiple myeloma].
Nishimura K; Kawada M; Suehiro T; Yamano T; Hashimoto K
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1087-94. PubMed ID: 1363243
[TBL] [Abstract][Full Text] [Related]
14. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions].
Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV
Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303
[TBL] [Abstract][Full Text] [Related]
15. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.
Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M
Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302
[TBL] [Abstract][Full Text] [Related]
16. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
17. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C
Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733
[TBL] [Abstract][Full Text] [Related]
18. Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia.
Jepson RE; Vallance C; Syme HM; Elliott J
Am J Vet Res; 2010 Feb; 71(2):241-7. PubMed ID: 20113234
[TBL] [Abstract][Full Text] [Related]
19. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
20. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
